We are live on ! Find out more
PARS

PHARMOS CORP NEW
PARS

Delisted

PARS was delisted on the 12th of March, 2009.

Back to rankings

1 hedge funds and large institutions have $12 invested in PHARMOS CORP NEW in 2016 Q3 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
1
Holders Change
+1
Holders Change %
–
% of All Funds
0.03%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
SIM
Sonora Investment Management
Arizona
+$12

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
SIM
1
Sonora Investment Management
Arizona
$12 +$12 +1,000 New

PARS Hedge Fund Activity: Q3 2016 in Review

1 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in PHARMOS CORP NEW (PARS) for Q3 2016, worth a combined $12.

Buyers outnumbered sellers: 1 fund opened new PARS positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Sonora Investment Management, opening a new position worth an estimated $12.

  • 1 institutional investor held PHARMOS CORP NEW (PARS) as of Q3 2016, up from 0 in Q2 2016.
  • Funds reported $12 of PHARMOS CORP NEW stock for Q3 2016.
  • 1 fund opened new PHARMOS CORP NEW positions in Q3 2016 and 0 closed out, a net change of +1 holder.
  • The largest PHARMOS CORP NEW buyer in Q3 2016 was Sonora Investment Management, an estimated $12 added.

Based on aggregated 13F filings for Q3 2016.